IMG INST FUER MEDIZINISCHE GENOMFORSCHUNG PLANUNGSGESELLSCHAFT M B H has a total of 12 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement and biotechnology are ZHENGZHOU ZHONGDAO BIOTECHNOLOGY CO LTD, PUSCAS IOAN and GUIZHOU KWINBN FOOD SAFETY SCIENCE AND TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Klocker Helmut | 9 |
#2 | Sueltmann Holger | 7 |
#3 | Schaefer Georg | 6 |
#4 | Faelth Maria | 4 |
#5 | Chui Pressinotti Nicole | 4 |
#6 | Enot David | 3 |
#7 | Weinberger Klaus | 3 |
#8 | Van Duc Luu | 3 |
#9 | Dallmann Guido | 3 |
#10 | Deigner Hans-Peter | 3 |
Publication | Filing date | Title |
---|---|---|
EP2700949A1 | Use of biliverdin reductase proteins as cancer marker | |
EP2607493A1 | Diagnosis of steatohepatitis | |
EP2574929A1 | Marker in diagnosing prostate cancer (PC) | |
EP2354794A1 | Diagnosing prostate cancer relapse | |
EP2320235A1 | Marker for prostate cancer diagnosis | |
EP2320234A1 | Marker combination for prostate cancer diagnosis |